Sentences with phrase «genomics research center»

Edythe Broad and Eli Broad mingle with the crowd as Eric Lander, director of the Broad Institute, and Aviv Regev, chat with them, right to left, after a 2005 press conference at the Cambridge genomics research center.

In 2014, The Jackson Laboratory opened a state - of - the - art genomics research center on the campus of the University of Connecticut Health Center in Farmington, Conn..

Before Editas, she was Entrepreneur - in - Residence at The Broad Institute, a biomedical and genomic research center, and prior to that, she was President and CEO of Avila Therapeutics.

PALO ALTO, Calif., April 06, 2016 — Cloudera, the global provider of the fastest, easiest, and most secure data management and analytics platform built on Apache Hadoop and the latest open source technologies, today announced a collaboration with the Broad Institute of MIT and Harvard, the world's leading biomedical and genomic research center.

Not exact matches

Future resources from the NCI Center for Cancer Genomics (CCG), which oversees TCGA and other activities, will support more translationally focused research, including databases with genomic information on clinical samples linked to outcomes of their patient donors.

A decade ago, this week, scientists at the University of Texas Health Science Center at Houston and the Institute for Genomic Research announced they had decoded the genetic information inside Treponema pallidum, the bacterium that causes the sexually transmitted disease (STD) syphilis.

Maine also approved bond measures to create an animal and plant disease and insect control lab, build a genomics and disease research center, and modernize and expand a biological lab specializing in tissue repair and regeneration.

If the findings of the study are replicated in other animal models, such as pigs, they could have considerable implications for public health, says Oluf Pedersen, professor of genomic medicine at the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen.

Motivation for building a system of research excellence is what drives Miguel Beato, who as director of the Center for Genomic Regulation, or Centre de Regulació Genòmica (CRG), an international research institute in Barcelona, is contributing to the national metamorphosis.

The regulatory function of novel targets will be validated in collaboration with Judy H. Cho, MD, Ward - Coleman Professor of Medicine and Genetics and Genomic Sciences, and Assistant Chief of Research in the Gastrointestinal Division, and Jean Federic Colombel, MD, Professor of Medicine and Director of the Leona M. and Harry B. Helmsley Charitable Trust Inflammatory Bowel Disease Center, at they Icahn School of Medicine at Mount Sinai.

At the German Cancer Research Center, (Deutsches Krebsforschungszentrum, or DKFZ) in Heidelberg, scientists working in precision oncology are also taking full advantage of advances in genomic technology.

Other educational events include a 3 - day workshop on genomics given by faculty members from the University of Michigan's Center for Statistical Consultation and Research and weekly colloquia with special events.

University of Washington Center for Genomic and Health Care Equality; Stanford University School of Medicine Center for Integration of Research on Genetics and Ethics; the Duke Center for the Study of Public Genomics; Case Western Reserve University Center for Genetic Research Ethics and Law; Center for Genomics and Society at the University of North Carolina at Chapel Hill; University of Pennsylvania Center for the Integration of Genetics Healthcare Technology

Maine: Voters approved Question 4, 63.1 % to 36.9 %, providing $ 10 million in bonds, to be matched by $ 11 million in private funds, to build a genomics and disease research center at the Maine Technology Institute in Brunswick.

«Comparing genomic information across species allows us to glean important information about ourselves,» said Eric Lander, director of the Whitehead / MIT Center for Genome Research and lead author of the 42 - page report on the mouse genome.

This work was supported in part by the Center for Research in FOP and Related Disorders, the International FOP Association, the Ian Cali Endowment, the Weldon Family Endowment, the Penn Center for Musculoskeletal Disorders, the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine, and the Deutsche Forschungsgemeinschaft (SFB760 to P. Seemann and S. Mundlos); by Health and Labour Science Research Grants for Research on Measures for Intractable Disease Research and the Academic Frontier Project of Saitma Medical University Research Center for Genomic Medicine, both from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (to T. Katagiri); and by grants from the Rita Allen Foundation and the NIH (R01 - GM056326 to M.C. Mullins; R01 - AR40196 to F.S. Kaplan and E.M. Shore).

A collaboration of premier academic, medical and industry leaders across the globe, the New York Genome Center has as its goal to translate genomic research into the development of new treatments, therapies and therapeutics against human disease.

«The availability of the human genome sequence, as well as other genomic resources produced by our sequencing centers, has transformed biomedical research everywhere,» said NHGRI's Associate Director of Extramural Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research research everywhere,» said NHGRI's Associate Director of Extramural Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research Research Network.

7Division of Pathophysiology, Research Center for Genomic Medicine, Saitama Medical University, Yamane, Hidaka - shi, Saitama, Japan.

This seems fair and reasonable, since there's an entire institute at the NIH designed to fund cancer research, but it kind of sucks if your sequencing center spent the last eight years building a reputation in cancer genomics.

In addition to Doñana Biological Station (EBD - CSIC), also taking part in the project were the National Center for Genomic Analysis (CNAG - CRG); the Centre for Genomic Regulation (CRG); the Spanish National Cancer Research Center (CNIO); the Evolutionary Genomics Group of the Hospital del Mar Medical Research Institute (IMIM); the Institute of Evolutionary Biology (IBE, CSIC - UPF); the University Institute of Oncology of Asturias (IUOPA); the Institut de Biotecnologia i de Biomedicina and the Unit of Cell Culture of the Autonomous University of Barcelona (UAB); the Biological Research Center (CIB - CSIC) and the Catalan Institution for Research and Advanced Studies (ICREA).

He recently moved back to academia as an associate professor in the departments of Neuroscience and Human Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York, where he continues his basic research and translational efforts in AD using a state - of - the - art experimental and computational toolkit, in collaboration with Drs. Alison Goate and Anne Schaefer within the Ronald M. Loeb Center for Alzheimer's Disease.

Participating institutions: Helmholtz Association • CNRS • Institute of Molecular Biotechnology • Research Center for Molecular Medicine of the Austrian Academy of Sciences • VIB - KU Leuven • Friedrich Miescher Institute for Biomedical Research • University of Basel • University of Zurich • Central European Institute of Technology • Max Planck Institute of Immunobiology and Epigenetics • Max Planck Institute for Molecular Genetics • German Cancer Research Center • Max Delbrück Center for Molecular Medicine • German Center for Neurodegenerative Diseases • Helmholtz Zentrum München • Max Planck Institute for Evolutionary Anthropology • Helmholtz Institute of RNA - based Infection Research • Saarland University • Technical University Munich • University of Würzburg • Biotech Research & Innovation Centre • Interdisciplinary Nanoscience Center • University of Copenhagen • Centre for Genomic Regulation • Institut Curie • Université de Montpellier • Inserm • Université Toulouse III — Paul Sabatier • École nationale supérieure des mines de Paris • Institute for Molecular Medicine Finland • The Biomedical Research Foundation, Academy of Athens • Weizmann Institute of Science • Hebrew University • Sapienza — University of Rome • Instituto Nazionale Genetica Molecolare • University of Napoli • University of Padua • University of Milan • European Institute of Oncology • Netherlands Cancer Institute • Radboud University • University Medical Center Utrecht • Hubrecht Institute • Instituto Gulbenkian de Ciência • Institute of Bioorganic Chemistry of the Polish Academy of Sciences • Romanian Center for Systems Immunology • Karolinska Institute • MRC Human Genetics Unit • University of Edinburgh • Wellcome Sanger Institute • The Babraham Institute • European Molecular Biology Laboratory — European Bioinformatics Institute

Dr. Torkamani's research covers a broad range of areas centered on the use of genomic technologies to identify the genetic etiology and underlying mechanisms of human disease in order to define precision therapies for diseased individuals.

He currently, holds a joint post-doctoral research position in the labs of Peter Kharchenko, Department of Biomedical Informatics at Harvard Medical School and Dr. Roy Perlis, Center for Genomic Medicine at Massachusetts General Hospital.

October 28, 2009 Dr. Charis Eng delivers Keynote Address at the University of Alabama, Birmingham Comprehensive Cancer Center Research Retreat Charis Eng, MD, PhD, FACP, Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine, and Founding Chair and Director of the Genomic Medicine Institute delivered the Keynote Address entitled, «Germline homozygosity, cancer predisposition and tumor microenvironment.»

Included among the numerous recipients of Mr. Sanford's gifts, that total more than one billion dollars, are: the Edith Sanford Foundation for Breast Cancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medicine.

«Autism's Unexpected Link to Cancer Gene,» highlighted recent research conducted by Charis Eng, MD, PhD, Chair of the Genomic Medicine Institute, in collaboration with Thomas Frazier, MD, Director of the Cleveland Clinic's Center for Autism.

The Genomic Medicine Institute (GMI) and the Center for Clinical Genomics are excited to announce a broad research collaboration with Human Longevity Inc., (HLI), Dr. J. Craig Venter's company in San Diego, CA.

Charis Eng, MD, PhD, Hardis Chair of the Genomic Medicine Institute (GMI) and Director of The Center for Personalized Genetic Healthcare (CPGH), has been awarded a Clinical Research Mentorship grant from the Doris Duke Charitable Foundation (DDCF).

A team led by Sekar Kathiresan — founder of the Myocardial Infarction Genetics Consortium, institute member and co-director of the Medical and Populations Genetics Program at the Broad Institute, and director of the Center for Genomic Medicine at Massachusetts General Hospital — and Rajat Gupta, a postdoctoral research fellow in Kathiresan's lab, recently revisited this spot in the genome to map it and determine the mechanisms by which one DNA variant could affect so many disorders.

The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation.

Center will utilize next generation genomic sequencing and analysis technologies to better understand infectious disease pathogens, and create resource for the research community

His honours and awards include the inaugural Gutenberg Professorship of the University of Strasbourg, the Order of Australia and Australian Government Centenary Medal, Fellowship of the Australian Academy of Science, Associate Membership of the European Molecular Biology Organization, Honorary Fellowship of the Royal College of Pathologists of Australasia, the International Union of Biochemistry & Molecular Biology Medal, the Human Genome Organisation Chen Award for Distinguished Achievement in Human Genetic & Genomic Research, and the University of Texas MD Anderson Cancer Center Bertner Memorial Award for Distinguished Contributions to Cancer Research.

He has worked with the Naval Medical Research Center to develop the Empowering the Development of Geonomic Expertise (EDGE), which has raised the Laboratory's prominence in genomics to a new level.

«Jim Mullikin is the ideal choice to champion the broad scientific portfolio of the NIH Intramural Sequencing Center, which is one of NHGRI's premiere research assets,» said NHGRI Scientific Director Daniel Kastner, M.D., Ph.D. «Dr. Mullikin brings a comprehensive experiential and academic background to NISC, taking on the wealth of basic and clinical research initiatives already underway and planning for the genomic contributions that this center will be making well into the future.&Center, which is one of NHGRI's premiere research assets,» said NHGRI Scientific Director Daniel Kastner, M.D., Ph.D. «Dr. Mullikin brings a comprehensive experiential and academic background to NISC, taking on the wealth of basic and clinical research initiatives already underway and planning for the genomic contributions that this center will be making well into the future.&center will be making well into the future.»

Elizabeth Winzeler, PhD Professor of Pediatrics, Division of Pharmacology and Drug Discovery University of California, San Diego, School of Medicine Director of Translational Research, UC Health Sciences Center for Immunology, Infection and Inflammation Talk title: Using chemical genomics to find new targets for malaria elimination

Her research centers on a broad range of topics in functional evolutionary genomics.

Dr. Rehm also co-leads a new Center for Mendelian Genomics and conducts research in hearing loss, Usher syndrome, cardiomyopathy, healthcare IT and genomic medicine.

«The ORIEN network of cancer centers is made up of true partners in data exchange and we are proud to extend these benefits to patients in the form of genomic data research that will help us better understand cancer at the molecular level and hopefully develop more targeted cancer treatments.»

To boost the impact of our pioneering colorectal cancer research, our projects rely on the expertise of several Moon Shot platforms, including Proteomics, IACS, Center for Co-Clinical Trials and Cancer Genomic Laboratory.

The J. Craig Venter Institute is a not - for - profit research institute which through its two operating divisions, The Institute for Genomic Research (TIGR) and The Center for the Advancement of Genomics (TCAG) advances the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policresearch institute which through its two operating divisions, The Institute for Genomic Research (TIGR) and The Center for the Advancement of Genomics (TCAG) advances the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policResearch (TIGR) and The Center for the Advancement of Genomics (TCAG) advances the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers.

From the Department of Medicine, Division of Hematology, Brigham and Women's Hospital (S.J., A.J.S., M.M.) and Harvard Medical School (B.L.E.), the Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital (E.S.) and Harvard Medical School (G.K.S., P.L.), the Department of Pathology (S.J.) and the Center for Genomic Medicine (P.N., S.K.), Massachusetts General Hospital, the Department of Medicine, Division of Cardiology, and Cardiovascular Research Center (P.N., S.K.), and the Department of Medicine (A.G.B.), Massachusetts General Hospital and Harvard Medical School, and the Departments of Medical Oncology (C.J.G.) and Biostatistics and Computational Biology (D.N.), Dana - Farber Cancer Institute, Boston, and the Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge (P.N., A.G.B., N.G., S.G., S.K.)- all in Massachusetts; the Department of Cardiology, University Hospital, Parma, Italy (D.A.); the Department of Medicine, Division of Cardiology, Mt. Sinai School of Medicine, New York (U.B., R.M., V.F.); Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid (V.F.); Medical Research Council - British Heart Foundation Cardiovascular Epidemiology Unit and National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, and the British Heart Foundation, Cambridge Centre of Excellence, Department of Medicine, University of Cambridge, Cambridge (J.D.), and the Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton (J.D.)- both in the United Kingdom; the Center for Non-Communicable Diseases, Karachi, Pakistan (P.F., D.S.); the Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia (D.S.); and the Department of Clinical Sciences Malmö, Lund University, Lund, Sweden (O.M.).

James Allison, professor of immunology and chair of the Department of Immunology, The University of Texas MD Anderson Cancer Center Lieping Chen, United Technologies Corporation Professor in Cancer Research and professor of immunobiology, of dermatology and of medicine, Yale University Gordon Freeman, professor of medicine, Dana - Farber Cancer Institute, Harvard Medical School Tasuku Honjo, professor of immunology and genomic medicine, Kyoto University Arlene Sharpe, the George Fabyan Professor of Comparative Pathology, Harvard Medical School; senior scientist, department of pathology, Brigham and Women's Hospital

The NHGRI - supported, large - scale sequencing centers, their principal investigators and their approximate FY 2004 funding levels are: Agencourt Bioscience Corp., Beverly, Mass., Douglas R. Smith, Ph.D., $ 10 million; Baylor College of Medicine, Houston, Richard Gibbs, Ph.D., $ 35 million; The Eli & Edythe L. Broad Institute, Massachusetts Institute of Technology (MIT), Eric Lander, Ph.D., Cambridge, Mass., $ 59 million; The Institute for Genomic Research, J. Craig Venter Science Foundation Joint Technology Center, Rockville, Md., J. Craig Venter, Ph.D., $ 10 million; and Washington University School of Medicine, Saint Louis, Richard K. Wilson, Ph.D., $ 49 million.

The Jackson Laboratory for Genomic medicine is a new research center that discovers precise genomic solutions for dGenomic medicine is a new research center that discovers precise genomic solutions for dgenomic solutions for disease.

The Broads work to create lasting positive change through institutions like high - quality public charter schools, genomics and stem cell research centers and contemporary art museums like The Broad in downtown Los Angeles.

Alliance for Climate Education The Altshuller Institute for TRIZ Studies American Geological Institute American Society of Heating, Refrigerating, and Air - Conditioning Engineers (ASHRAE) Apollo Alliance Arizona State University Appalachian State University PSM in Engineering Physics - Instrumentation and Automation Association of American Universities Association of Public and Land - grant Universities Babson College Babson College Energy and Environmental Club Baker College Berkeley Energy Resources Collaborative Binghamton University - State University of New York Bloomsburg University Boston University Energy Club Breakthrough Institute CSTEM Teacher and Student Support Services The California State University California State University - Bakersfield California State University - Channel Islands California State University - Chico California State University - East Bay California State University - Fresno California State University - Fresno PSM Programs in Biotechnology and Water Resources California State University - San Bernardino California State University - Stanislaus California State University - Stanislaus PSM Program in Genetic Counseling Center for Genomic Sciences - Allegheny - Singer Research Institute Clemson University Columbia University Cornell University Council of Graduate Schools Council on Undergraduate Research Duke University EAST Initiative emPOWER, Brown University Student Energy Group Energy Action Coalition Engineers Without Borders - USA Florida Atlantic University Florida State University Focus the Nation Georgia Institute of Technology Global Exchange Harvard College Environmental Action Committee IEEE - USA LearnOnLine, Inc..